This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Blood Pressure
and you are
between 18 and 55
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The study is conducted: - to investigate the influence of sunitinib (study drug) on the plasma biomarkers VEGF-A, VEGF-C, soluble VEGFR-2, and soluble VEGFR-3 (vessel endothelial growth factors) and on the blood pressure; - to generate a pharmacokinetic/pharmacodynamic model for sunitinib using biomarkers.

Provided treatments

  • Drug: sunitinib (Sutent)
Tris trial is registered with FDA with number: NCT00904657. The sponsor of the trial is University of Cologne and it is looking for 12 volunteers for the current phase.
Official trial title:
An Open-label One-way Explorative Study on the Pharmacokinetics and Pharmacodynamics of Sunitinib in Healthy Volunteers